IFNG and cancer: Emerging data suggest that chronic upregulation of interferon-gamma (IFN-γ) response pathways is a key driver of acquired resistance.11–13 So-called adaptive immune resistance (AIR) in cancer describes the various mechanisms by which tumors adapt to evade anti-tumor immune responses.